Avista Healthcare Partners Acquires Trillium Health Care Products

Avista Healthcare Partners Launches Birchwell Consumer Health and Acquires Bag Balm

May 4, 2026

Healthcare Services

Avista Healthcare Partners launched Birchwell Consumer Health as a new U.S. consumer healthcare platform focused on acquiring OTC and skincare brands. Birchwell’s first acquisition is Bag Balm, a Vermont-based therapeutic skincare brand acquired from a seller group led by Gemini Investors.

Avista Healthcare Partners Acquires PK Benelux

November 20, 2025

Healthcare Services

Avista Healthcare Partners completed its acquisition of PK Benelux, a leading Netherlands-based vitamins, minerals, and supplements (VMS) company known for the Lucovitaal brand. The deal strengthens Avista’s consumer health platform and supports continued growth in the Netherlands and broader Western European markets.

Avista Capital Partners Acquires WellSpring Consumer Healthcare

August 23, 2022

Consumer Products

Avista Capital Partners completed the acquisition of WellSpring Consumer Healthcare from Audax Private Equity. WellSpring, founded in 1999 and headquartered in Sarasota, Florida, is a developer and marketer of over-the-counter and personal care brands (including Bactine, Bonine, Emetrol and Glaxal Base); Avista plans to support growth through product innovation, distribution expansion and strategic acquisitions.

Avista Capital Partners and VHC Investco Acquire Vision Healthcare NV

June 1, 2020

Consumer Products

Avista Capital Partners, together with VHC Investco and company management, acquired Belgium-based Vision Healthcare NV in a transaction valuing the company at €305 million (approximately $336 million). Avista and VHC Investco/management will each hold a 50% ownership interest; the partnership will support Vision's omni-channel, direct-to-consumer growth and geographic expansion across Europe and beyond.

Karo Pharma Acquires Trimb Healthcare from Avista Capital Partners

June 25, 2019

Pharmaceuticals

Karo Pharma AB (publ) has signed a definitive agreement to acquire Trimb Healthcare from Avista Capital Partners for SEK 3.4 billion. Trimb, a Stockholm‑based consumer healthcare company with ~90 employees and a portfolio of OTC brands, will expand Karo Pharma's geographic presence, distribution channels and product offerings in the Nordic and Northern European consumer health market.

Cambrex Acquires Avista Pharma Solutions

January 2, 2019

Pharmaceuticals

Cambrex Corporation completed the acquisition of Avista Pharma Solutions from Ampersand Capital Partners in a transaction announced November 20, 2018 and completed January 2019 (reported consideration about $252 million). The deal brings Avista’s early‑stage drug development, analytical/testing and finished dosage capabilities (sites in Longmont, CO; Durham, NC; Agawam, MA; and Edinburgh, UK) into Cambrex’s global CDMO network to expand capabilities and cross‑sell services.